These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 28420941)

  • 1. Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.
    Guan Q; Zhang J
    Mediators Inflamm; 2017; 2017():4810258. PubMed ID: 28420941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
    Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
    Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trefoil factors in inflammatory bowel disease.
    Aamann L; Vestergaard EM; Grønbæk H
    World J Gastroenterol; 2014 Mar; 20(12):3223-30. PubMed ID: 24696606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD.
    León AJ; Gómez E; Garrote JA; Bernardo D; Barrera A; Marcos JL; Fernández-Salazar L; Velayos B; Blanco-Quirós A; Arranz E
    Mediators Inflamm; 2009; 2009():580450. PubMed ID: 19657406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation.
    Nikolaus S; Bauditz J; Gionchetti P; Witt C; Lochs H; Schreiber S
    Gut; 1998 Apr; 42(4):470-6. PubMed ID: 9616306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
    Scheibe K; Kersten C; Schmied A; Vieth M; Primbs T; Carlé B; Knieling F; Claussen J; Klimowicz AC; Zheng J; Baum P; Meyer S; Schürmann S; Friedrich O; Waldner MJ; Rath T; Wirtz S; Kollias G; Ekici AB; Atreya R; Raymond EL; Mbow ML; Neurath MF; Neufert C
    Gastroenterology; 2019 Mar; 156(4):1082-1097.e11. PubMed ID: 30452921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.
    Østvik AE; Svendsen TD; Granlund AVB; Doseth B; Skovdahl HK; Bakke I; Thorsvik S; Afroz W; Walaas GA; Mollnes TE; Gustafsson BI; Sandvik AK; Bruland T
    J Crohns Colitis; 2020 Jul; 14(7):920-934. PubMed ID: 32020185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
    Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
    Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease.
    Pereira C; Grácio D; Teixeira JP; Magro F
    Inflamm Bowel Dis; 2015 Oct; 21(10):2403-17. PubMed ID: 26193347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.
    Bilski J; Mazur-Bialy A; Wojcik D; Surmiak M; Magierowski M; Sliwowski Z; Pajdo R; Kwiecien S; Danielak A; Ptak-Belowska A; Brzozowski T
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease.
    Cominelli F; Pizarro TT
    Aliment Pharmacol Ther; 1996; 10 Suppl 2():49-53; discussion 54. PubMed ID: 8899101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in understanding the role of cytokines in inflammatory bowel disease.
    Bevivino G; Monteleone G
    Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):907-915. PubMed ID: 30024302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?
    de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G Protein-Coupled Receptor 30 (GPR30) Expression Pattern in Inflammatory Bowel Disease Patients Suggests its Key Role in the Inflammatory Process. A Preliminary Study.
    Włodarczyk M; Sobolewska-Włodarczyk A; Cygankiewicz AI; Jacenik D; Piechota-Polańczyk A; Stec-Michalska K; Krajewska WM; Fichna J; Wiśniewska-Jarosińska M
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):29-35. PubMed ID: 28338111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of mucosal inflammation in pediatric inflammatory bowel disease: striking overexpression of IL-17A in children with ulcerative colitis.
    Busch MA; Gröndahl B; Knoll RL; Pretsch L; Doganci A; Hoffmann I; Kullmer U; Bähner V; Zepp F; Meyer CU; Gehring S
    Pediatr Res; 2020 Apr; 87(5):839-846. PubMed ID: 31261370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.
    Verdier J; Begue B; Cerf-Bensussan N; Ruemmele FM
    Inflamm Bowel Dis; 2012 Jul; 18(7):1260-6. PubMed ID: 21994045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine expression in gingival and intestinal tissues of patients with periodontitis and inflammatory bowel disease: An exploratory study.
    Menegat JS; Lira-Junior R; Siqueira MA; Brito F; Carvalho AT; Fischer RG; Figueredo CM
    Arch Oral Biol; 2016 Jun; 66():141-6. PubMed ID: 26946440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-10 and IL-10 receptor defects in humans.
    Glocker EO; Kotlarz D; Klein C; Shah N; Grimbacher B
    Ann N Y Acad Sci; 2011 Dec; 1246():102-7. PubMed ID: 22236434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease.
    Fu SH; Chien MW; Hsu CY; Liu YW; Sytwu HK
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.